Stepping away from the trend of mystery thrillers and chamber dramas in contemporary Bengali cinema, Dev — who is the main ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' next-generation treatment for a rare and ...

First approved in 2021, Jemperli has now become a cornerstone of GSK’s cancer business, earning more than $160 million in the ...

Our top content for the year highlight many challenges the field of non–small cell lung cancer (NSCLC) encountered, with data ...

A hearing for Meade was held Dec. 10 where his public defender Anne Taylor highlighted issues with his housing at the Nez ...

The OnePlus 13R basically has a different name in China, and it will launch on December 26. The global model is coming on ...

Vauxhall will launch a hydrogen powered version of its Movano large van next year. The Movano Hydrogen will be priced from ...

Preliminary findings from the phase 2 SENTRY trial (NCT04562389) demonstrated that the combination of selinexor (Xpovio) plus ...

The FDA issues a complete response letter to JNJ's BLA seeking approval for the subcutaneous formulation of Rybrevant in EGFR-mutated non-small cell lung cancer.

Both vibostolimab and favezelimab have had disappointing runs leading up to their termination, sustaining several late-stage ...

In addition to the progression-free survival primary endpoint, the tafasitamab arm also had a higher rate of complete ...